Disposable POC Device Introduced for Low-Resource Areas
|
By LabMedica International staff writers Posted on 05 Sep 2017 |

Image: Paper-based diagnostic device that detects biomarkers and identifies diseases by performing electrochemical analyses. The assays change color to indicate specific test results. The device can be plugged into the handheld potentiostat, at left (Photo courtesy of Purdue University, Aniket Pal).
A recent paper described a novel diagnostic device fabricated from various types of paper to be used for point-of-care testing in areas lacking electricity and other resources.
The developers at Purdue University (West Lafayette, IN, USA) used different types of paper to fabricate Self-powered, Paper-based Electrochemical Devices (SPEDs) that were designed for sensitive diagnostics in low-resource settings. SPEDs are inexpensive, lightweight, mechanically flexible, easy to use, and disposable by burning.
The top layer of the SPED was prepared from cellulose paper with patterned hydrophobic domains that delineated hydrophilic, wicking-based microfluidic channels for accurate colorimetric assays, and self-pipetting test zones for electrochemical detection.
The bottom layer of the SPED was a triboelectric generator (TEG) made from hydrophobic paper and capable of harvesting electrical energy from the user's interaction with the SPED.
An inexpensive and rechargeable handheld potentiostat was constructed to interface with the SPED, enabling the accurate quantitative electrochemical detection of glucose, uric acid, and L-lactate. The battery powering the potentiostat could be recharged by the user, using the sequential discharge of a capacitor previously charged with the TEG built into the SPED.
A machine-vision diagnostic application was created to automatically identify and quantify each of the colorimetric tests from a digital image of the SPED, taken under a wide range of ambient light conditions, in order to provide fast diagnostic results to the user as well as to facilitate remote expert consultation.
"To our knowledge, this work reports the first self-powered, paper-based devices capable of performing rapid, accurate, and sensitive electrochemical assays in combination with a low-cost, portable potentiostat that can be recharged using a paper-based TEG," said contributing author Dr. Ramses V. Martinez, assistant professor of industrial and biomedical engineering at Purdue University. "You could consider this a portable laboratory that is just completely made out of paper, is inexpensive and can be disposed of through incineration. We hope these devices will serve untrained people located in remote villages or military bases to test for a variety of diseases without requiring any source of electricity, clean water, or additional equipment."
SPEDs were described in detail in the August 22, 2017, online edition of the journal Advanced Materials Technologies.
Related Links:
Purdue University
The developers at Purdue University (West Lafayette, IN, USA) used different types of paper to fabricate Self-powered, Paper-based Electrochemical Devices (SPEDs) that were designed for sensitive diagnostics in low-resource settings. SPEDs are inexpensive, lightweight, mechanically flexible, easy to use, and disposable by burning.
The top layer of the SPED was prepared from cellulose paper with patterned hydrophobic domains that delineated hydrophilic, wicking-based microfluidic channels for accurate colorimetric assays, and self-pipetting test zones for electrochemical detection.
The bottom layer of the SPED was a triboelectric generator (TEG) made from hydrophobic paper and capable of harvesting electrical energy from the user's interaction with the SPED.
An inexpensive and rechargeable handheld potentiostat was constructed to interface with the SPED, enabling the accurate quantitative electrochemical detection of glucose, uric acid, and L-lactate. The battery powering the potentiostat could be recharged by the user, using the sequential discharge of a capacitor previously charged with the TEG built into the SPED.
A machine-vision diagnostic application was created to automatically identify and quantify each of the colorimetric tests from a digital image of the SPED, taken under a wide range of ambient light conditions, in order to provide fast diagnostic results to the user as well as to facilitate remote expert consultation.
"To our knowledge, this work reports the first self-powered, paper-based devices capable of performing rapid, accurate, and sensitive electrochemical assays in combination with a low-cost, portable potentiostat that can be recharged using a paper-based TEG," said contributing author Dr. Ramses V. Martinez, assistant professor of industrial and biomedical engineering at Purdue University. "You could consider this a portable laboratory that is just completely made out of paper, is inexpensive and can be disposed of through incineration. We hope these devices will serve untrained people located in remote villages or military bases to test for a variety of diseases without requiring any source of electricity, clean water, or additional equipment."
SPEDs were described in detail in the August 22, 2017, online edition of the journal Advanced Materials Technologies.
Related Links:
Purdue University
Latest Technology News
- Artificial Intelligence Model Could Accelerate Rare Disease Diagnosis
- AI Saliva Sensor Enables Early Detection of Head and Neck Cancer
- AI-Powered Biosensor Technology to Enable Breath Test for Lung Cancer Detection
- AI Model Achieves Breakthrough Accuracy in Ovarian Cancer Detection
- Portable Biosensor Diagnoses Psychiatric Disorders Using Saliva Samples
- Cell-Sorting Device Uses Electromagnetic Levitation to Precisely Direct Cell Movement

- Embedded GPU Platform Enables Rapid Blood Profiling for POC Diagnostics
- Viral Biosensor Test Simultaneously Detects Hepatitis and HIV
- Acoustofluidic Device to Transform Point-Of-Care sEV-Based Diagnostics
- AI Algorithm Assesses Progressive Decline in Kidney Function
Channels
Clinical Chemistry
view channel
Chemical Imaging Probe Could Track and Treat Prostate Cancer
Prostate cancer remains a leading cause of illness and death among men, with many patients eventually developing resistance to standard hormone-blocking therapies. These drugs often lose effectiveness... Read more
Mismatch Between Two Common Kidney Function Tests Indicates Serious Health Problems
Creatinine has long been the standard for measuring kidney filtration, while cystatin C — a protein produced by all human cells — has been recommended as a complementary marker because it is influenced... Read moreMolecular Diagnostics
view channel
Simple Urine Test to Revolutionize Bladder Cancer Diagnosis and Treatment
Bladder cancer is one of the most common and deadly urological cancers and is marked by a high rate of recurrence. Diagnosis and follow-up still rely heavily on invasive cystoscopy or urine cytology, which... Read more
Blood Test to Enable Earlier and Simpler Detection of Liver Fibrosis
Persistent liver damage caused by alcohol misuse or viral infections can trigger liver fibrosis, a condition in which healthy tissue is gradually replaced by collagen fibers. Even after successful treatment... Read moreHematology
view channel
Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk
Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more
Microvesicles Measurement Could Detect Vascular Injury in Sickle Cell Disease Patients
Assessing disease severity in sickle cell disease (SCD) remains challenging, especially when trying to predict hemolysis, vascular injury, and risk of complications such as vaso-occlusive crises.... Read more
ADLM’s New Coagulation Testing Guidance to Improve Care for Patients on Blood Thinners
Direct oral anticoagulants (DOACs) are one of the most common types of blood thinners. Patients take them to prevent a host of complications that could arise from blood clotting, including stroke, deep... Read moreImmunology
view channel
New Test Distinguishes Vaccine-Induced False Positives from Active HIV Infection
Since HIV was identified in 1983, more than 91 million people have contracted the virus, and over 44 million have died from related causes. Today, nearly 40 million individuals worldwide live with HIV-1,... Read more
Gene Signature Test Predicts Response to Key Breast Cancer Treatment
DK4/6 inhibitors paired with hormone therapy have become a cornerstone treatment for advanced HR+/HER2– breast cancer, slowing tumor growth by blocking key proteins that drive cell division.... Read more
Chip Captures Cancer Cells from Blood to Help Select Right Breast Cancer Treatment
Ductal carcinoma in situ (DCIS) accounts for about a quarter of all breast cancer cases and generally carries a good prognosis. This non-invasive form of the disease may or may not become life-threatening.... Read moreMicrobiology
view channel
Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
Sepsis kills 11 million people worldwide every year and generates massive healthcare costs. In the USA and Europe alone, sepsis accounts for USD 100 billion in annual hospitalization expenses.... Read moreRapid POC Tuberculosis Test Provides Results Within 15 Minutes
Tuberculosis remains one of the world’s deadliest infectious diseases, and reducing new cases depends on identifying individuals with latent infection before it progresses. Current diagnostic tools often... Read more
Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read morePathology
view channel
Tunable Cell-Sorting Device Holds Potential for Multiple Biomedical Applications
Isolating rare cancer cells from blood is essential for diagnosing metastasis and guiding treatment decisions, but remains technically challenging. Many existing techniques struggle to balance accuracy,... Read moreAI Tool Outperforms Doctors in Spotting Blood Cell Abnormalities
Diagnosing blood disorders depends on recognizing subtle abnormalities in cell size, shape, and structure, yet this process is slow, subjective, and requires years of expert training. Even specialists... Read moreIndustry
view channel
Abbott Acquires Cancer-Screening Company Exact Sciences
Abbott (Abbott Park, IL, USA) has entered into a definitive agreement to acquire Exact Sciences (Madison, WI, USA), enabling it to enter and lead in fast-growing cancer diagnostics segments.... Read more




 assay.jpg)



